Venomous organisms have evolved a variety o
f structurally diverse peptide neurotoxins thattarget ion channels. Despite the lack o
f any obvious structural homology, unrelated toxins that interactwith voltage-activated K
+ channels share a dyad moti
f composed o
f a lysine and a hydrophobic aminoacid residue, usually a phenylalanine or a tyrosine.
fchars/kappa.gi
f" BORDER=0 >M-Conotoxin RIIIK (
fchars/kappa.gi
f" BORDER=0 >M-RIIIK), recently characterized
from the cone snail
Conus radiatus, blocks
Shaker and
TSha1 K
+ channels. The
functional and structuralstudy presented here reveals that
fchars/kappa.gi
f" BORDER=0 >M-conotoxin RIIIK blocks voltage-activated K
+ channels with a novelpharmacophore that does not comprise a dyad moti
f. Despite the quite di
fferent amino acid sequence andno overlap in the pharmacological activity, we
found that the NMR solution structure o
f fchars/kappa.gi
f" BORDER=0 >M-RIIIK in theC-terminal hal
f is highly similar to that o
f f">-conotoxin GIIIA, a speci
fic blocker o
f the skeletal muscleNa
+ channel Na
v1.4. Alanine substitutions o
f all non-cysteine residues indicated that
four amino acids o
ffchars/kappa.gi
f" BORDER=0 >M-RIIIK (Leu1, Arg10, Lys18, and Arg19) are key determinants
for interaction with K
+ channels.Following the hypothesis that Leu1, the major hydrophobic amino acid determinant
for binding, serves asthe hydrophobic partner o
f a dyad moti
f, we investigated the e
ffect o
f several mutations o
f Leu1 on thebiological
function o
f fchars/kappa.gi
f" BORDER=0 >M-RIIIK. Surprisingly, both the structural and mutational analysis suggested that,uniquely among well-characterized K
+ channel-targeted toxins,
fchars/kappa.gi
f" BORDER=0 >M-RIIIK blocks voltage-gated K
+ channelswith a pharmacophore that is
not organized around a lysine-hydrophobic amino acid dyad moti
f.